A practical look at Gnani Evon v3.3's hybrid MoE architecture, Indic-language benchmarks, use cases, deployment options, and limitations.
When Xaira Therapeutics debuted in 2024 with a gobsmacking $1 billion in funding, a natural expectation would have been for a ...
Crohn’s disease is one of medicine’s most frustrating puzzles. A chronic inflammatory bowel condition that can strike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results